ArticlePLOS global public health2021
Vaccine rollout strategies: The case for vaccinating essential workers early.
Article in PLOS global public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed, 59 citations in OpenAlex.
- An online community peer support intervention to promote COVID-19 vaccine information among essential workers: a randomized trial.Annals of medicine · 2022Trial
- Modeling individual self-protective behavior during epidemics.PLoS computational biology · 2026Article
- On value compatibility: reflections on the ethical framework for pandemic healthcare distribution.Medicine, health care, and philosophy · 2025Article
- The decision uncertainty toolkit: Risk measures and visual outputs to support decision making during public health crises.PloS one · 2025Article
- Rollout designs for lump-sum data.Journal of applied statistics · 2025Article
- Canada's provincial COVID-19 pandemic modelling efforts: A review of mathematical models and their impacts on the responses.Canadian journal of public health = Revue canadienne de sante publique · 2024Review
- Examining the Influence of Imbalanced Social Contact Matrices in Epidemic Models.American journal of epidemiology · 2024Article
- Healthcare costs and effects of post-COVID-19 condition in Canada.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2023Article
- Modelling lifespan reduction in an exogenous damage model of generic disease.Scientific reports · 2023Article
- Evaluating vaccine allocation strategies using simulation-assisted causal modeling.Patterns (New York, N.Y.) · 2023Article
- Doubt in store: vaccine hesitancy among grocery workers during the COVID-19 pandemic.Journal of behavioral medicine · 2023Article
- Extensive SARS-CoV-2 testing reveals BA.1/BA.2 asymptomatic rates and underreporting in school children.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2023Article
- The optimal allocation of Covid-19 vaccines.Economics letters · 2023Article
- COVID-19 endgame: From pandemic to endemic? Vaccination, reopening and evolution in low- and high-vaccinated populations.Journal of theoretical biology · 2023Article
- Fairness and efficiency considerations in COVID-19 vaccine allocation strategies: A case study comparing front-line workers and 65-74 year olds in the United States.PLOS global public health · 2023Article
- Article
- Medical Residents' Behaviours toward Compulsory COVID-19 Vaccination in a Tertiary Hospital in Italy.International journal of environmental research and public health · 2022Article
- Economic evaluation of COVID-19 rapid antigen screening programs in the workplace.BMC medicine · 2022Article
- Coronavirus Disease 2019 (COVID-19) Vaccine Prioritization in Low- and Middle-Income Countries May Justifiably Depart From High-Income Countries' Age Priorities.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022Article
- Mathematical modeling of COVID-19 in British Columbia: An age-structured model with time-dependent contact rates.Epidemics · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In vaccination campaigns against COVID-19, many jurisdictions are using age-based rollout strategies, reflecting the much higher risk of severe outcomes of infection in older groups. In the wake of growing evidence that approved vaccines are effective at preventing not only adverse outcomes, but also infection, we show that such strategies are less effective than strategies that prioritize essential workers. This conclusion holds across numerous outcomes, including cases, hospitalizations, Long COVID (cases with symptoms lasting longer than 28 days), deaths and net monetary benefit. Our analysis holds in regions where the vaccine supply is limited, and rollout is prolonged for several months. In such a setting with a population of 5M, we estimate that vaccinating essential workers sooner prevents over 200,000 infections, over 600 deaths, and produces a net monetary benefit of over $500M.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.